Failure of vitamin E in clinical trials: Is gamma-tocopherol the answer?

Sridevi Devaraj, Ishwarlal Jialal

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

Oxidative stress and inflammation play a crucial role in atherosclerosis. However, prospective clinical trials of dietary antioxidants with anti-inflammatory properties, such as α-tocopherol (AT), have not yielded positive results. AT supplementation decreases γ-tocopherol (GT) levels. GT is an antioxidant with potent anti-inflammatory activity, and plasma GT levels are inversely associated with cardiovascular diseases. Thus, studies using pure GT, alone or in conjunction with AT, will elucidate its utility in cardiovascular disease prevention.

Original languageEnglish (US)
Pages (from-to)290-293
Number of pages4
JournalNutrition Reviews
Volume63
Issue number8
DOIs
StatePublished - Aug 2005

Keywords

  • Antioxidant
  • Inflammation
  • Nitrative stress
  • Oxidative stress
  • Tocopherol

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Fingerprint Dive into the research topics of 'Failure of vitamin E in clinical trials: Is gamma-tocopherol the answer?'. Together they form a unique fingerprint.

  • Cite this